Raphael Mechoulam: The Father of Cannabis Research

The scientist whose work made modern cannabinoid medicine possible.

Almost everything we understand today about how cannabis affects the body traces back to one scientist: Raphael Mechoulam (1930–2023). An Israeli chemist often called the “father of cannabis research,” Mechoulam spent some six decades uncovering the chemistry of the cannabis plant and the biology of how it interacts with the human body. He passed away in March 2023, leaving behind a body of work that underpins the entire modern field of cannabinoid science.

Isolating THC

In 1964, working with his colleague Yehiel Gaoni, Mechoulam isolated delta-9-tetrahydrocannabinol (THC) in pure form and determined its chemical structure — the first time anyone had clearly identified the plant's main psychoactive compound. (The pair had already elucidated the structure of cannabidiol, or CBD, the year before, in 1963.) It's hard to overstate how foundational this was: until then, cannabis had remained a scientific puzzle, its active ingredients unidentified. Pinning down THC reactivated cannabis research worldwide and made it possible, for the first time, to study the plant's effects with real precision.

Discovering the Body's Own Cannabinoids

Mechoulam's second landmark contribution came decades later. In the early 1990s, his laboratory helped reveal that the human body produces its own cannabis-like molecules. In 1992, researchers in his lab — Lumír Hanuš and William Devane — isolated and characterized anandamide, the first identified “endocannabinoid.” A second, called 2-AG, followed soon after.

These discoveries were pivotal. They showed that the body has its own internal signaling network — what came to be called the endocannabinoid system — made up of these natural compounds, the receptors they act on, and the enzymes that build and break them down. That system, now understood to help regulate processes such as mood, pain, appetite, and memory, was mapped by many research groups around the world. But it was Mechoulam's identification of the body's own cannabinoids that opened the door to understanding it at all — a turning point for both neuroscience and pharmacology.

A Foundation for Modern Medicine

Mechoulam's research provided the scientific groundwork on which later cannabis-based medicines were built. His decades of work characterizing cannabinoids and how they behave in the body helped make it possible for others to develop therapeutic applications — including treatments for epilepsy, pain, and chemotherapy-induced nausea. He was also known within the scientific community as a generous collaborator who shared credit readily and built strong research teams.

Beyond the laboratory, Mechoulam's careful, evidence-driven work reshaped how the public and the medical profession viewed cannabis. He advocated not through slogans but through data — and in doing so contributed to the gradual acceptance of medical cannabis around the world. His legacy is the reason a field of cannabinoid medicine exists for patients and clinicians to draw on today.

This article is for general educational and historical information only and is not medical advice. Please consult a qualified healthcare professional for guidance on cannabis and your individual health.